S L Liauw

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience
    Stanley L Liauw
    Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, 75390 9110, USA
    Urology 61:1204-10. 2003
  2. doi request reprint Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging
    Stanley L Liauw
    Department of Radiation Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Int J Radiat Oncol Biol Phys 85:378-84. 2013
  3. pmc Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation
    Daniel W Golden
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Radiat Oncol 7:156. 2012
  4. pmc Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy
    Kevin S Choe
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Clin Oncol 30:3540-4. 2012
  5. doi request reprint Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
    Cancer 115:1784-90. 2009
  6. ncbi request reprint Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer
    S L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Technol Cancer Res Treat 8:201-6. 2009
  7. pmc Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 77:125-30. 2010
  8. doi request reprint Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer
    Stanley L Liauw
    Department Radiation and Cellular Oncology, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 81:751-7. 2011
  9. doi request reprint The use of capecitabine in the combined-modality therapy for rectal cancer
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Clin Colorectal Cancer 7:99-104. 2008
  10. doi request reprint Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, 5758 S Maryland Avenue, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 71:1316-21. 2008

Detail Information

Publications29

  1. ncbi request reprint Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience
    Stanley L Liauw
    Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, 75390 9110, USA
    Urology 61:1204-10. 2003
    ....
  2. doi request reprint Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging
    Stanley L Liauw
    Department of Radiation Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Int J Radiat Oncol Biol Phys 85:378-84. 2013
    ....
  3. pmc Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation
    Daniel W Golden
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Radiat Oncol 7:156. 2012
    ..We investigated whether the radiation dose used in chemoradiation (CRT) as definitive treatment for UPC and the CA 19-9 response to therapy have an impact on overall survival (OS)...
  4. pmc Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy
    Kevin S Choe
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Clin Oncol 30:3540-4. 2012
    ..Experimental evidence suggests that anticoagulants (ACs) may inhibit cancer growth and metastasis, but clinical data have been limited. We investigated whether use of ACs was associated with the risk of death from prostate cancer...
  5. doi request reprint Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA
    Cancer 115:1784-90. 2009
    ..However, the value of concurrent ADT was less certain with dose-escalated RT. Better methods of stratifying patients in this risk group may help select patients who are most likely to benefit...
  6. ncbi request reprint Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer
    S L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Technol Cancer Res Treat 8:201-6. 2009
    ..By last follow-up late Grade 3+ toxicity was 2% for both GI and GU systems. In conclusion, patients treated with IMRT for prostate cancer have excellent rates of biochemical control and low rates of severe toxicity of treatment...
  7. pmc Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 77:125-30. 2010
    ..The present study reviewed the outcomes of intermediate- and high-risk men treated with RT and short-term ADT...
  8. doi request reprint Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer
    Stanley L Liauw
    Department Radiation and Cellular Oncology, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 81:751-7. 2011
    ..Prolongation of treatment time with radiation therapy (RT) is associated with inferior disease control for many rapidly proliferating tumors, but it is uncertain whether the same effect is seen in prostate cancer...
  9. doi request reprint The use of capecitabine in the combined-modality therapy for rectal cancer
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Clin Colorectal Cancer 7:99-104. 2008
    ..This review discusses the evolution of combined-modality therapy for rectal cancer with specific attention given to the use of capecitabine in conjunction with radiation therapy...
  10. doi request reprint Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, 5758 S Maryland Avenue, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 71:1316-21. 2008
    ..Radioimmunoscintigraphy (RIS) has the potential to demonstrate early recurrences after prostatectomy and might be useful in selecting patients for salvage radiotherapy (RT)...
  11. doi request reprint Statin use and risk of prostate cancer recurrence in men treated with radiation therapy
    Ruchika Gutt
    Department of Radiation and Cellular Oncology, University of Chicago, 5758 S Maryland Avenue, Chicago, IL 60637, USA
    J Clin Oncol 28:2653-9. 2010
    ..The primary objective of this study was to determine whether statin use is associated with improved clinical outcomes in patients treated with radiotherapy (RT) for prostate cancer...
  12. doi request reprint The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy
    Kevin S Choe
    Department Radiation and Cellular Oncology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
    Cancer 116:1820-6. 2010
    ..The potential antineoplastic effect of ACs was investigated in patients who received radiotherapy for localized prostate cancer...
  13. ncbi request reprint Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience
    Joseph K Salama
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    J Clin Oncol 25:4581-6. 2007
    ..To report a multicenter experience treating anal canal cancer patients with concurrent chemotherapy and intensity-modulated radiation therapy (IMRT)...
  14. doi request reprint External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity
    Kiran Devisetty
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 77:1060-5. 2010
    ..To describe genitourinary (GU) toxicity in men with a history of transurethral resection of the prostate (TURP) treated with external beam radiation therapy (EBRT) for prostate cancer...
  15. doi request reprint External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
    Kevin S Choe
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 76:755-60. 2010
    ..To characterize the bleeding toxicity associated with external beam radiotherapy for prostate cancer patients receiving anticoagulation (AC) therapy...
  16. doi request reprint Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
    Ruchika Gutt
    Department of Radiation and Cellular Oncology, University of Chicago, IL 60637, USA
    Nat Clin Pract Gastroenterol Hepatol 6:38-46. 2009
    ..This article reviews the studies--prospective and retrospective--of adjuvant radiotherapy for pancreatic cancer and the issues surrounding the use of this strategy...
  17. doi request reprint Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis
    Kapila Kalakota
    Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Brachytherapy 9:131-6. 2010
    ..To describe the rate of gastrointestinal (GI) toxicity after prostate brachytherapy and describe how external beam radiation therapy (EBRT) may influence the association of rectal dose-volume histogram (DVH) parameters with rectal toxicity...
  18. ncbi request reprint Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up
    Stanley L Liauw
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 66:669-73. 2006
    ..To report the incidence of second bladder and colorectal cancers after prostate brachytherapy...
  19. doi request reprint The role of radiotherapy in locally advanced pancreatic carcinoma
    Ruchika Gutt
    Department of Radiation and Cellular Oncology, University of Chicago Hospital, Chicago, IL 60637, USA
    Nat Rev Gastroenterol Hepatol 7:437-47. 2010
    ..We focus on the benefits associated with local therapies, including radiotherapy and surgical resection, as they relate to improved local disease control, prolonged overall survival and improved symptom control...
  20. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  21. ncbi request reprint Radiotherapy after subtotally resected or recurrent ganglioglioma
    Stanley L Liauw
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL 32610 0385, USA
    Int J Radiat Oncol Biol Phys 67:244-7. 2007
    ..Salvage RT for recurrence is probably less effective for long-term control; however, patients who recur may still be candidates for effective salvage therapies in the absence of malignant transformation...
  22. ncbi request reprint Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease
    Stanley L Liauw
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA
    Cancer 100:920-8. 2004
    ..The objectives of this study were to summarize a single-institution experience in treating patients with inflammatory breast carcinoma (IBC) using trimodality therapy and to identify prognostic factors for outcome...
  23. ncbi request reprint Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck
    Stanley L Liauw
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA
    Head Neck 29:715-9. 2007
    ..The role of salvage neck dissection for isolated regional recurrences after definitive radiotherapy (RT) is ill-defined...
  24. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  25. pmc The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, 1365 Clifton Road, NE, Suite A1300, Atlanta, GA 30322, USA
    Clin Med Res 5:123-31. 2007
    ..The larger RIS-guided target volumes do not appear to be prohibitive in increasing radiotherapy-related toxicity. Future directions of the use of RIS for post-RRP prostate cancer are discussed...
  26. doi request reprint Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
    Am J Clin Oncol 31:375-8. 2008
    ..The objective of this investigation was to use the Surveillance, Epidemiology, and End Results (SEER) registry to examine time trends in age and grade...
  27. doi request reprint Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?
    Anamaria R Yeung
    Department of Radiation Oncology, University of Florida, Gainesville, FL 32610 0385, USA
    Cancer 112:1076-82. 2008
    ..The purpose was to determine if postradiotherapy (RT) neck dissection can be limited to the neck levels of residual adenopathy on post-RT computed tomography (CT)...